Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies

@article{Studerus2011AcuteSA,
  title={Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies},
  author={E. Studerus and M. Kometer and F. Hasler and Franz X Vollenweider},
  journal={Journal of Psychopharmacology},
  year={2011},
  volume={25},
  pages={1434 - 1452}
}
  • E. Studerus, M. Kometer, +1 author Franz X Vollenweider
  • Published 2011
  • Medicine, Psychology
  • Journal of Psychopharmacology
    • Psilocybin and related hallucinogenic compounds are increasingly used in human research. However, due to limited information about potential subjective side effects, the controlled medical use of these compounds has remained controversial. We therefore analysed acute, short- and long-term subjective effects of psilocybin in healthy humans by pooling raw data from eight double-blind placebo-controlled experimental studies conducted between 1999 and 2008. The analysis included 110 healthy… CONTINUE READING
    View on SAGE
    ouramazingworld.org
    196 Citations
    Highly Influential Citations
    26
    Background Citations
    90
    Methods Citations
    10
    Results Citations
    16

    Figures, Tables, and Topics from this paper

    Figures and Tables

    Explore Further: Topics Discussed in This Paper

    196 Citations
    Citation Type

    Citation Type

    Dose-related effects of salvinorin A in humans: dissociative, hallucinogenic, and memory effects
    • 84
    Post-acute psychological effects of classical serotonergic psychedelics: a systematic review and meta-analysis
    Psilocybin: Psychotherapy or drug?
    • G. Goodwin
    • Medicine
    • Journal of psychopharmacology
    • 2016
    • 5
    • PDF
    Psilocybin dose-dependently causes delayed, transient headaches in healthy volunteers.
    • 61
    High dose psilocybin is associated with positive subjective effects in healthy volunteers
    • 7
    Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin.
    Long-lasting subjective effects of LSD in normal subjects
    • 48
    • PDF
    Long-term effects of psychedelic drugs: A systematic review
    • 6
    Tolerability, assessment, and prediction of psilocybin-induced altered states of consciousness
    • 5
    Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years
    • 111
    • PDF

    References

    SHOWING 1-10 OF 168 REFERENCES
    Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder.
    • 246
    • PDF
    Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose–effect study
    • 208
    • PDF
    The Effects of the Preferential 5-HT2A Agonist Psilocybin on Prepulse Inhibition of Startle in Healthy Human Volunteers Depend on Interstimulus Interval
    • 93
    • PDF
    Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d-methamphetamine in healthy volunteers Results of an experimental double-blind placebo-controlled study
    • 125
    • PDF
    ADVERSE REACTIONS TO PSYCHEDELIC DRUGS. A REVIEW OF THE LITERATURE
    • R. Strassman
    • Psychology, Medicine
    • The Journal of nervous and mental disease
    • 1984
    • 182
    Comparison of the reactions induced by psilocybin and LSD-25 in man
    • H. Isbell
    • Psychology, Medicine
    • Psychopharmacologia
    • 2004
    • 62
    Effects of psilocybin on time perception and temporal control of behaviour in humans
    • 128
    • PDF
    Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance
    • 657
    • PDF
    Effects of the hallucinogen psilocybin on habituation and prepulse inhibition of the startle reflex in humans
    • 66
    Mescaline, lysergic acid diethylamide and psilocybin comparison of clinical syndromes, effects on color perception and biochemical measures.
    • 52